11/20
04:30 pm
irtc
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
Low
Report
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
11/18
08:15 am
irtc
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
Medium
Report
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
11/5
04:30 pm
irtc
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
Low
Report
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
11/1
09:00 pm
irtc
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Medium
Report
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
11/1
09:02 am
irtc
Here's Why iRhythm Technologies (IRTC) Slid in Q3 [Yahoo! Finance]
Medium
Report
Here's Why iRhythm Technologies (IRTC) Slid in Q3 [Yahoo! Finance]
11/1
08:15 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Robert W. Baird from $100.00 to $79.00. They now have an "outperform" rating on the stock.
Medium
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Robert W. Baird from $100.00 to $79.00. They now have an "outperform" rating on the stock.
10/31
09:32 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Needham & Company LLC from $119.00 to $96.00. They now have a "buy" rating on the stock.
Low
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Needham & Company LLC from $119.00 to $96.00. They now have a "buy" rating on the stock.
10/30
05:15 pm
irtc
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
Medium
Report
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
10/30
04:08 pm
irtc
iRhythm Technologies Announces Third Quarter 2024 Financial Results
Low
Report
iRhythm Technologies Announces Third Quarter 2024 Financial Results
10/28
08:06 am
irtc
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy [Yahoo! Finance]
Low
Report
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy [Yahoo! Finance]
10/28
08:02 am
irtc
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
Low
Report
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
10/25
05:38 pm
irtc
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
Low
Report
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
10/23
09:10 am
irtc
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Low
Report
iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock? [Yahoo! Finance]
10/22
01:39 pm
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target raised by analysts at Truist Financial Co. from $80.00 to $95.00. They now have a "buy" rating on the stock.
Low
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target raised by analysts at Truist Financial Co. from $80.00 to $95.00. They now have a "buy" rating on the stock.
10/22
01:34 pm
irtc
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says [Yahoo! Finance]
Low
Report
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says [Yahoo! Finance]
10/21
04:05 pm
irtc
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
High
Report
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
10/16
04:05 pm
irtc
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
Low
Report
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
10/14
10:35 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Truist Financial Co. from $117.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target lowered by analysts at Truist Financial Co. from $117.00 to $80.00. They now have a "buy" rating on the stock.
10/11
07:51 pm
irtc
IRHYTHM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
Low
Report
IRHYTHM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
10/11
06:59 am
irtc
Irhythm Technologies Outlines Growth and Market Leadership Strategy [Yahoo! Finance]
Low
Report
Irhythm Technologies Outlines Growth and Market Leadership Strategy [Yahoo! Finance]
10/4
08:06 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $78.00 price target on the stock.
Medium
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $78.00 price target on the stock.
9/30
12:08 pm
irtc
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
Low
Report
IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
9/27
02:02 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
9/25
11:05 am
irtc
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $122.00 to $137.00. They now have a "buy" rating on the stock.
Low
Report
iRhythm Technologies, Inc. (NASDAQ: IRTC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $122.00 to $137.00. They now have a "buy" rating on the stock.
9/20
08:00 am
irtc
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm
Medium
Report
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm